A number of people have posted links about some of the below developments in the last post, and several people have also e-mailed me relevant links
NAMs do not enter you into a CTN faster, because the CTN does not assess your nonclinical package in detail
Moreover, the applicant stated that the existing pass-through code C1781 does not appropriately describe the Axoguard HA+ Nerve Protector TM because the nominated device is indicated specifically for management of peripheral nerve injuries, whereas devices described by C1781 are for use in hernia repair
Benefits (Research Focus) Studied for tendon and ligament repair in connective tissue regeneration models Investigated for muscle healing and regenerative signaling after injury Explored for gastric and intestinal lining protection in GI research Examined for angiogenesis and new blood vessel formation in healing tissues Researched for fibroblast migration, collagen deposition, and nitric oxide pathway modulation What Researchers Look At Angiogenesis and vascularization endpoints in soft tissue recovery models Fibroblast migration, collagen synthesis, and wound closure rates Gastrointestinal mucosal integrity in NSAID and stress-induced injury models Tendon-to-bone healing and ligament reconstruction in surgical research Neuroprotective and anti-inflammatory signaling in preclinical research Quick Specs Form: Gelatin capsule Strength: 500 mcg / capsule (0.5 mg) Quantity: 30 capsules per bottle Salt Form: L-Arginine salt (stabilized for oral administration) Excipient: Microcrystalline cellulose (MCC) pharmaceutical-grade filler Purity: 99% Storage: Store in a cool, dry, dark place Identity Basics Compound: BPC-157 (Body Protection Compound-157) Synonyms: PL 14736
The benzyl alcohol and water can separate to a degree during phase transition
